Report Critical of CERN Fails to Identify Savings

LONDON—An international review of the European Organization for Nuclear Research (CERN) in Geneva has dealt a double blow to the laboratory's administration. Severely critical of CERN's management, accounting and personnel policies, it nevertheless has not identified cash savings that would persuade Britain to remain a member of Europe's premier high-energy physics center. The review panel, set up at Britain's instigation, presented its interim findings to CERN's council in early June. It

Written byJon Turney
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The review panel, set up at Britain's instigation, presented its interim findings to CERN's council in early June. Its most urgent recommendation is to freeze long-term appointments and shrink the 3,500-member staff by 500 in the next two years. Unless CERN takes this step, the group's unpublished interim report said, "it is doomed to paralysis of an all-too-familiar kind" by a static and aging workforce.

But paying off departing staff members would cost extra money in the short term, and Britain's motive in demanding the review was to find budget savings. An earlier British review of the nation's contribution to particle physics recommended that the country spend no more than £30 million ($48 million) at CERN each year. That figure was repeated in this year's spending advice to the government from the Advisory Board for the Research Councils (ABRC). The board then said further action should be delayed pending the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies